Navigation Links
ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement
Date:1/6/2009

Deal Paves Way For Use of ALD Ultra High-k Insulators; Marks Transition to 3x nm Memory Nodes

ALMERE, The Netherlands and ST. LOUIS, Jan. 6 /PRNewswire-FirstCall/ -- ASM International N.V. (Nasdaq: ASMI; Euronext Exchange in Amsterdam: ASM) and SAFC Hitech(TM), a business segment within SAFC(R), a member of the Sigma-Aldrich(R) Group (Nasdaq: SIAL), today announced that they have entered into a certified manufacturer and partnership agreement for certain Atomic Layer Deposition (ALD) source materials for advanced Ultra High-k insulators. The agreement provides certification criteria for the chemical source materials, a license to certain ASM ALD patents and a partnership for the marketing and further development of these chemical source materials.

The newly developed 'cyclopentadienyl' source materials will enable ALD of next generation Strontium and Barium based Ultra High-k insulators with dielectric constants exceeding 100. By comparison, the Zirconium and Hafnium based High-k insulators that are in production today have dielectric constants less than 30 to 40. An insulator with a higher dielectric constant is expected to allow device manufacturers to produce much smaller capacitors for DRAM memory chips, and microprocessors with smaller transistors. These Ultra High-k materials are expected to be needed for production of 3x nm node memories, beginning around 2011.

"We see Moore's law being increasingly enabled by the ability to produce and integrate new materials in the chip manufacturing process," said Dr. Ivo Raaijmakers, ASM's Chief Technology Officer and Director of R&D. "Partnership agreements such as this will allow us to develop new materials much more efficiently, and to prepare the supply chain fo
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group
2. Probiotic Delivery Technology Awarded Third International Patent
3. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement
4. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
5. Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots
6. MINRAD International, Inc. Announces Reduction in Workforce
7. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
8. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
9. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
10. International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research
11. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009).../PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc.(...duledtopresentatthePiperJaffray21stAnnualHealthCar...8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewYo...eOfficer,isscheduledtoprovideanoverviewofthecompan...ams. ,, Aliveaudiowebcastofthepresentationwillb...
(Date:11/24/2009)...swire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasda...iperJaffrayHealthCareConference.Theconferencewillb..., CTIwillpresentonTuesday,December1at11:00a.m.Eas...,spresentationwillbeavailableat www.celltherapeuti...s. , ,PiperJaffrayHealthCareConference,NewYorkPal...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(PD...ishedNovember27,2009astheex-dividenddateforits$200...hesecuritizationtransactioncompletedonNovember2,20...kholdersofrecordontherecorddate,December1,2009.NAS...at$1.67pershareofcommonstockforpurposesoftheex-div...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...hances NeoStem,s Presence in Anti-Aging Arena , ,...US: NBS), which is pioneering the pre-disease coll...stem cells for future medical need, announced toda...exclusive worldwide rights to innovative stem cell...nd body procedures and skin rejuvenation. , , The...
...D, Pa., Feb. 23 Endo Pharmaceuticals (Nasdaq: E... the tender offer by its wholly owned subsidiary, ...res of common stock of Indevus Pharmaceuticals, In...; Trust Company, the depositary for the tender off...rk City time, on February 20, 2009, the initial ex...
..., Calif., Feb. 23 CUREXO Technology Corporation, ...age-directed robotic products for orthopaedic appl...C(R) Surgical System, announced today that they wi...ion of Orthopaedic Surgeons Annual Conference at t...hrough the 27th, Booth #3456. , , For the first t...
Other Biology Technology:NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 2NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 3Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 2Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 3CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2
(Date:11/24/2009)...able in Spanish . , The presence of increas...matory substances in the blood, hinders the loss a...rch project of the University of Navarra conducted...chool of Pharmacy. , The project, entitled "A nu...he control of body weight and inflammation," exami...
(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 1Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 1TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 4Cohen Launches Second Statewide Tour 57485 1Cohen Launches Second Statewide Tour 57485 2
...stralian researchers have discovered a new gene th...ate cancer, as well as diabetes. , The gene, calle...ustralian Institute for Medical Research,s (WAIMR)...Peter Leedman, in collaboration with Professor Ber... Texas. , "When we baited our hook and went fishi...
...the transport of proteins within cells may underli...such as Huntington,s, ALS and Kennedy disease. Und...hese diseases may offer targets for future therapy...re Neuroscience, researchers from the University o...ow a chemical pathway that is obstructed in Kenned...
...f UniQuest,s 2006 Trailblazer innovation competiti... for motoneuronal diseases based on modifying boto...onal diseases cause a degeneration of the nerve pa...re severe and physically debilitating disorders wh...cles. Many of the diseases are incurable. , Dr Me...
Other Biology News:Gene discovery opens door to tackling disease 2Mechanism for neurodenegerative diseases linked to transport proteins 2
...orm 96 assays on one plate. The new ArraySlide 96 ...mm) individual printing surfaces for multiple simu...alysis studies. Unlike other systems, this device ... presence of contaminating adhesives. The chamber ...
...orm 96 assays on four slides. The new ArraySlide 2...mm x 7mm) individual printing surfaces for multipl...ing analysis studies. Unlike other systems, this d...ng the presence of contaminating adhesives. The ch...
...integrins in vascular proliferation, adhesion, and...rin family of cell adhesion receptors consists of ...osed of an a and b subunit that associate in a non...ersity of the integrin family are based upon the p...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: